SCHEMBL6354500

SCHEMBL6354500

O=[N+]([O-])c1cc(-c2ncco2)ccc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.47
LMNA P02545 4/20 0.47
HTT P42858 3/20 0.47
ALDH1A1 P00352 3/20 0.46
HIF1A Q16665 1/20 0.46
VCAM1 P19320 1/20 0.44
KCNJ1 P48048 1/20 0.43
KCNH2 Q12809 1/20 0.43
TDP1 Q9NUW8 3/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
POLB P06746 2/20 0.39
KDM4E B2RXH2 1/20 0.39
THRB P10828 1/20 0.39
PKM P14618 1/20 0.39
IDO1 P14902 1/20 0.39
RECQL P46063 1/20 0.39
TDO2 P48775 1/20 0.39
BLM P54132 1/20 0.39
CASP6 P55212 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1127050 0.88 TDP1 (0.47) MAPTLMNAHTTALDH1A1HIF1A
SCHEMBL29033804 0.84 KCNJ1 (0.44) MAPTALDH1A1KCNJ1KCNH2TDP1
SCHEMBL27218089 0.82 MAPT (0.55) MAPTLMNAALDH1A1VCAM1KCNJ1
SCHEMBL1830727 0.79 NPC1 (0.55) MAPTLMNAHTTALDH1A1KCNJ1
SCHEMBL6114155 0.77 ALDH1A1 (0.54) MAPTLMNAHTTALDH1A1KCNJ1
SCHEMBL11579276 0.77 ALDH1A1 (0.67) MAPTLMNAHTTALDH1A1HIF1A
SCHEMBL27631548 0.75 ALDH1A1 (0.51) MAPTLMNAHTTALDH1A1HIF1A
SCHEMBL23850950 0.75 MAPT (0.63) MAPTLMNAALDH1A1POLBPKM
SCHEMBL984873 0.74 KCNJ1 (0.67) MAPTLMNAALDH1A1KCNJ1KCNH2
SCHEMBL18731512 0.74 KCNJ1 (0.45) MAPTLMNAALDH1A1KCNJ1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050090498-A1 3-Quinolin-2(1h)-ylideneindolin-2-one derivative YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 2005-04-28 US disclosed
EP-1396490-A1 3-QUINOLINE-2-(1H)-YLIDENEINDOLIN-2-ONE DERIVATIVES YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 2004-03-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050090498-A1 3-Quinolin-2(1h)-ylideneindolin-2-one derivative KDR, FLT4, FLT1 MAPT 3729/4885LMNA 4317/4885HTT 4341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.